Login / Signup

Recent landscape and trends for industry-sponsored pediatric clinical trials in China from 2013 to 2022.

Chang LiuYi LiuLing OuYuenan QiJianmin Zhang
Published in: Pediatric investigation (2024)
The growth trends for industry-sponsored clinical trials involving children illustrate the progress and increasing capability of pediatric drug development achieved in China since 2013. Current challenges and potential areas of focus for policymakers and stakeholders include investigating orphan drugs for rare diseases according to the unique epidemiological characteristics of Chinese children, expanding the scope of pediatric clinical trials, and improving the uneven geographical distribution of leading research centers.
Keyphrases
  • clinical trial
  • young adults
  • phase ii
  • open label
  • study protocol
  • childhood cancer